"Arginine Vasopressin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.
| Descriptor ID |
D001127
|
| MeSH Number(s) |
D06.472.699.631.692.781.100 D12.644.400.900.100 D12.644.456.925.100 D12.644.548.691.692.781.100 D12.776.631.650.937.100
|
| Concept/Terms |
Arginine Vasopressin- Arginine Vasopressin
- Argipressin
- Arg-Vasopressin
- Arg Vasopressin
- Vasopressin, Arginine
|
Below are MeSH descriptors whose meaning is more general than "Arginine Vasopressin".
Below are MeSH descriptors whose meaning is more specific than "Arginine Vasopressin".
This graph shows the total number of publications written about "Arginine Vasopressin" by people in this website by year, and whether "Arginine Vasopressin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arginine Vasopressin" by people in Profiles.
-
Sex differences in associations of arginine vasopressin and oxytocin with resting-state functional brain connectivity. J Neurosci Res. 2017 01 02; 95(1-2):576-586.
-
Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull. 2014 Nov; 40(6):1374-84.
-
Chronic exposure to stress hormones alters the subtype of store-operated channels expressed in H19-7 hippocampal neuronal cells. J Cell Physiol. 2013 Jun; 228(6):1332-43.
-
Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation. Liver Transpl. 2008 Nov; 14(11):1664-70.
-
Slowing the progression of CHF. Drug therapy to correct neurohormonal abnormalities. Postgrad Med. 2001 Mar; 109(3):36-8, 41-5.
-
Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest. 1998 Jan 15; 101(2):464-70.
-
Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry. 1997 May; 54(5):443-9.
-
Role of vasopressin in essential hypertension: racial differences. J Hypertens. 1997 May; 15(5):545-50.
-
Endothelin-1 and vasopressin signalling in blood vessels of young SHR in comparison to adult SHR. Hypertens Res. 1996 Jun; 19(2):121-32.
-
Oropharyngeal regulation of water balance in polydipsic schizophrenics. Clin Endocrinol (Oxf). 1996 Jan; 44(1):31-7.